Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China
· Delayed Price · Currency is CNY 34.25
-0.70 (-2.00%)
Last updated: Jun 25, 2025
SHE:301263 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 83.11 | 97.04 | 153.5 | 174.61 | 120.07 | 160.83 | Upgrade
|
Depreciation & Amortization | 53.99 | 53.99 | 39.04 | 33.07 | 28.25 | 22.65 | Upgrade
|
Other Amortization | 1.08 | 1.08 | 0.62 | 0.76 | 1.06 | 1.59 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | -0.15 | -0.01 | 0.02 | 0.51 | Upgrade
|
Asset Writedown & Restructuring Costs | 1.27 | 1.27 | 7.61 | 0.3 | 3.34 | 8.11 | Upgrade
|
Loss (Gain) From Sale of Investments | -2.9 | -2.9 | -8.5 | -9.97 | -0.27 | -0.43 | Upgrade
|
Provision & Write-off of Bad Debts | 5.19 | 5.19 | 7.16 | 3.46 | - | - | Upgrade
|
Other Operating Activities | 16.71 | 8.62 | 1.75 | 6.03 | 4.3 | -2.14 | Upgrade
|
Change in Accounts Receivable | -28.87 | -28.87 | -70.77 | -64.03 | -55.86 | -63.83 | Upgrade
|
Change in Inventory | -17.43 | -17.43 | -9.41 | -4.67 | 23.25 | -7.05 | Upgrade
|
Change in Accounts Payable | -1.58 | -1.58 | -22.53 | 13.68 | 1.91 | -27.68 | Upgrade
|
Change in Other Net Operating Assets | -0.54 | -0.54 | -3.47 | 0.58 | -0.58 | 19.11 | Upgrade
|
Operating Cash Flow | 83.5 | 89.33 | 93.53 | 148.81 | 120.02 | 125.53 | Upgrade
|
Operating Cash Flow Growth | 404.55% | -4.48% | -37.15% | 23.99% | -4.38% | 66.39% | Upgrade
|
Capital Expenditures | -89.15 | -68.55 | -200.01 | -89.88 | -44.65 | -93.12 | Upgrade
|
Sale of Property, Plant & Equipment | 0 | 0.01 | 0.09 | 0.01 | 0.1 | 0.1 | Upgrade
|
Cash Acquisitions | - | - | -188.56 | - | - | - | Upgrade
|
Investment in Securities | 89 | 129 | -11 | -263.13 | 0.27 | 0.43 | Upgrade
|
Other Investing Activities | 5.65 | 5.8 | 8.55 | - | - | - | Upgrade
|
Investing Cash Flow | 5.5 | 66.26 | -390.93 | -353.01 | -44.29 | -92.59 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 107.51 | 127.01 | Upgrade
|
Long-Term Debt Issued | - | 244.5 | 173.64 | 20 | - | 0.35 | Upgrade
|
Total Debt Issued | 387.47 | 244.5 | 173.64 | 20 | 107.51 | 127.36 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -126.3 | -74.96 | Upgrade
|
Long-Term Debt Repaid | - | -180.47 | -21.55 | -110.86 | -5.52 | - | Upgrade
|
Total Debt Repaid | -279.47 | -180.47 | -21.55 | -110.86 | -131.82 | -74.96 | Upgrade
|
Net Debt Issued (Repaid) | 108 | 64.03 | 152.09 | -90.86 | -24.31 | 52.39 | Upgrade
|
Issuance of Common Stock | - | - | - | 1,078 | - | - | Upgrade
|
Repurchase of Common Stock | - | - | -39 | - | - | - | Upgrade
|
Common Dividends Paid | -135.89 | -135.12 | -166.78 | -85.81 | -4.27 | -68.14 | Upgrade
|
Dividends Paid | -135.89 | -135.12 | -166.78 | -85.81 | -4.27 | -68.14 | Upgrade
|
Other Financing Activities | -1.48 | - | - | -27.75 | -2.96 | -3.03 | Upgrade
|
Financing Cash Flow | -29.37 | -71.09 | -53.69 | 873.44 | -31.54 | -18.78 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.02 | 0.01 | -0.05 | -0.08 | -0.08 | -0.25 | Upgrade
|
Net Cash Flow | 59.66 | 84.52 | -351.14 | 669.17 | 44.12 | 13.9 | Upgrade
|
Free Cash Flow | -5.65 | 20.78 | -106.48 | 58.94 | 75.38 | 32.41 | Upgrade
|
Free Cash Flow Growth | - | - | - | -21.81% | 132.58% | -51.34% | Upgrade
|
Free Cash Flow Margin | -0.79% | 2.88% | -14.00% | 7.52% | 11.53% | 4.57% | Upgrade
|
Free Cash Flow Per Share | -0.01 | 0.05 | -0.25 | 0.15 | 0.24 | 0.11 | Upgrade
|
Cash Income Tax Paid | 92 | 98.3 | 114.1 | 55.56 | 59.65 | 87.62 | Upgrade
|
Levered Free Cash Flow | 19.43 | 82.8 | 10.05 | 23.05 | 43.07 | -34.81 | Upgrade
|
Unlevered Free Cash Flow | 25.12 | 88.2 | 11.11 | 24.66 | 46.02 | -31.6 | Upgrade
|
Change in Net Working Capital | -0.03 | -32.89 | -56.64 | 41.02 | 18.33 | 82.63 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.